adenosine-kinase and Fatty-Liver

adenosine-kinase has been researched along with Fatty-Liver* in 2 studies

Other Studies

2 other study(ies) available for adenosine-kinase and Fatty-Liver

ArticleYear
Endothelial adenosine kinase deficiency ameliorates diet-induced insulin resistance.
    The Journal of endocrinology, 2019, Volume: 242, Issue:2

    Insulin resistance-related disorders are associated with endothelial dysfunction. Accumulating evidence has suggested a role for adenosine signaling in the regulation of endothelial function. Here, we identified a crucial role of endothelial adenosine kinase (ADK) in the regulation of insulin resistance. Feeding mice with a high-fat diet (HFD) markedly enhanced the expression of endothelial Adk. Ablation of endothelial Adk in HFD-fed mice improved glucose tolerance and insulin sensitivity and decreased hepatic steatosis, adipose inflammation and adiposity, which were associated with improved arteriole vasodilation, decreased inflammation and increased adipose angiogenesis. Mechanistically, ADK inhibition or knockdown in human umbilical vein endothelial cells (HUVECs) elevated intracellular adenosine level and increased endothelial nitric oxide synthase (NOS3) activity, resulting in an increase in nitric oxide (NO) production. Antagonism of adenosine receptor A2b abolished ADK-knockdown-enhanced NOS3 expression in HUVECs. Additionally, increased phosphorylation of NOS3 in ADK-knockdown HUVECs was regulated by an adenosine receptor-independent mechanism. These data suggest that Adk-deficiency-elevated intracellular adenosine in endothelial cells ameliorates diet-induced insulin resistance and metabolic disorders, and this is associated with an enhancement of NO production caused by increased NOS3 expression and activation. Therefore, ADK is a potential target for the prevention and treatment of metabolic disorders associated with insulin resistance.

    Topics: Adenosine Kinase; Adipose Tissue; Animals; Cells, Cultured; Diet, High-Fat; Endothelium, Vascular; Fatty Liver; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Insulin Resistance; Male; Mice, Knockout; Mice, Transgenic; Nitric Oxide Synthase Type III; Obesity; Phosphorylation

2019
Neonatal hepatic steatosis by disruption of the adenosine kinase gene.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, May-14, Volume: 99, Issue:10

    Neonatal hepatic steatosis (OMIM 228100) is a fatal condition of unknown etiology characterized by a pale and yellow liver and early postnatal mortality. In the present study, a deficit in adenosine-dependent metabolism is proposed as a causative factor. Physiologically, adenosine is efficiently metabolized to AMP by adenosine kinase (ADK), an enzyme highly expressed in liver. ADK not only ensures normal adenine nucleotide levels but also is essential for maintaining S-adenosylmethionine-dependent transmethylation processes, where adenosine, an obligatory product, has to be constantly removed. Homozygous Adk(-/-) mutants developed normally during embryogenesis. However, within 4 days after birth they displayed microvesicular hepatic steatosis and died within 14 days with fatty liver. Adenine nucleotides were decreased and S-adenosylhomocysteine, a potent inhibitor of transmethylation reactions, was increased in the mutant liver. Thus, a deficiency in adenosine metabolism is identified as a powerful contributor to the development of neonatal hepatic steatosis, providing a model for the rapid development of postnatally lethal fatty liver.

    Topics: Adenine Nucleotides; Adenosine Kinase; Animals; Animals, Newborn; Apnea; Body Temperature; Disease Models, Animal; Fatty Liver; Female; Gene Targeting; Liver; Longevity; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; S-Adenosylhomocysteine

2002